Isao Kinoyama

1.0k total citations
16 papers, 826 citations indexed

About

Isao Kinoyama is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Isao Kinoyama has authored 16 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Genetics. Recurrent topics in Isao Kinoyama's work include Cell death mechanisms and regulation (7 papers), Cancer-related Molecular Pathways (5 papers) and Estrogen and related hormone effects (3 papers). Isao Kinoyama is often cited by papers focused on Cell death mechanisms and regulation (7 papers), Cancer-related Molecular Pathways (5 papers) and Estrogen and related hormone effects (3 papers). Isao Kinoyama collaborates with scholars based in Japan, Norway and United States. Isao Kinoyama's co-authors include Akira Matsuhisa, Masao Sasamata, Takahito Nakahara, Masahiro Takeuchi, Kentaro Yamanaka, Aya Kita, Masafumi Kudoh, Tsuyoshi Minematsu, Kenna Shirasuna and Hiroshi Koutoku and has published in prestigious journals such as Journal of the American Chemical Society, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Isao Kinoyama

15 papers receiving 816 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isao Kinoyama Japan 11 602 288 110 109 72 16 826
Takahito Nakahara Japan 13 947 1.6× 496 1.7× 153 1.4× 174 1.6× 109 1.5× 21 1.2k
Eric C. McGary United States 15 628 1.0× 480 1.7× 143 1.3× 134 1.2× 205 2.8× 22 1.1k
Richard Karlsson Denmark 13 601 1.0× 160 0.6× 48 0.4× 100 0.9× 110 1.5× 21 936
Vladimir Khazak United States 20 985 1.6× 298 1.0× 113 1.0× 73 0.7× 150 2.1× 34 1.2k
Alok R. Singh United States 16 494 0.8× 216 0.8× 74 0.7× 197 1.8× 177 2.5× 25 858
Sara C. Murphy United States 5 720 1.2× 268 0.9× 87 0.8× 88 0.8× 161 2.2× 9 885
Krista K. Bowman United States 10 929 1.5× 316 1.1× 75 0.7× 171 1.6× 157 2.2× 14 1.2k
Banibrata Sen United States 15 555 0.9× 358 1.2× 133 1.2× 85 0.8× 135 1.9× 21 923
Bhairavi Tolani United States 14 390 0.6× 226 0.8× 117 1.1× 71 0.7× 123 1.7× 18 743
Hidemi Hayashi Japan 14 801 1.3× 424 1.5× 67 0.6× 234 2.1× 107 1.5× 29 1.2k

Countries citing papers authored by Isao Kinoyama

Since Specialization
Citations

This map shows the geographic impact of Isao Kinoyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isao Kinoyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isao Kinoyama more than expected).

Fields of papers citing papers by Isao Kinoyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isao Kinoyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isao Kinoyama. The network helps show where Isao Kinoyama may publish in the future.

Co-authorship network of co-authors of Isao Kinoyama

This figure shows the co-authorship network connecting the top 25 collaborators of Isao Kinoyama. A scholar is included among the top collaborators of Isao Kinoyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isao Kinoyama. Isao Kinoyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Yamauchi, Tomohiro, Naoto Nakamura, Masashi Hiramoto, et al.. (2012). Sepantronium Bromide (YM155) induces disruption of the ILF3/p54nrb complex, which is required for survivin expression. Biochemical and Biophysical Research Communications. 425(4). 711–716. 62 indexed citations
2.
Nakamura, Naoto, Tomohiro Yamauchi, Masashi Hiramoto, et al.. (2012). Interleukin Enhancer-binding Factor 3/NF110 Is a Target of YM155, a Suppressant of Survivin. Molecular & Cellular Proteomics. 11(7). M111.013243–1. 60 indexed citations
3.
Nakahara, Takahito, Kentaro Yamanaka, Shinji Hatakeyama, et al.. (2011). YM155, a novel survivin suppressant, enhances taxane-induced apoptosis and tumor regression in a human Calu 6 lung cancer xenograft model. Anti-Cancer Drugs. 22(5). 454–462. 57 indexed citations
4.
Zakhari, Joseph S., Isao Kinoyama, Mark S. Hixon, et al.. (2011). Formulating a new basis for the treatment against botulinum neurotoxin intoxication: 3,4-Diaminopyridine prodrug design and characterization. Bioorganic & Medicinal Chemistry. 19(21). 6203–6209. 16 indexed citations
5.
Zakhari, Joseph S., et al.. (2011). Synthesis and Molecular Modeling Provide Insight into a Pseudomonas aeruginosa Quorum Sensing Conundrum. Journal of the American Chemical Society. 133(11). 3840–3842. 14 indexed citations
6.
Nakahara, Takahito, Aya Kita, Kentaro Yamanaka, et al.. (2010). Broad spectrum and potent antitumor activities of YM155, a novel small‐molecule survivin suppressant, in a wide variety of human cancer cell lines and xenograft models. Cancer Science. 102(3). 614–621. 132 indexed citations
7.
Kita, Aya, Takahito Nakahara, Masahiro Takeuchi, et al.. (2010). Survivin supressant: a promising target for cancer therapy and pharmacological profiles of YM155. Folia Pharmacologica Japonica. 136(4). 198–203. 6 indexed citations
8.
Yamanaka, Kentaro, Takahito Nakahara, Aya Kita, et al.. (2007). Concomitant and sequential administration of YM155 and docetaxel enhances apoptosis and tumor regression in human tumor xenograft models. Molecular Cancer Therapeutics. 6. 1 indexed citations
9.
Nakahara, Takahito, Masahiro Takeuchi, Isao Kinoyama, et al.. (2007). YM155, a Novel Small-Molecule Survivin Suppressant, Induces Regression of Established Human Hormone-Refractory Prostate Tumor Xenografts. Cancer Research. 67(17). 8014–8021. 412 indexed citations
10.
Nakahara, Takehiro, Makoto Takeuchi, Aya Kita, et al.. (2006). 396 POSTER Broad spectrum and potent anti tumor activity of YM155, a novel small moiecule survivin suppressant, against a large scale panel of human tumor cell lines. European Journal of Cancer Supplements. 4(12). 122–122. 1 indexed citations
11.
Kita, Aya, Takehiro Nakahara, Hiroshi Koutoku, et al.. (2006). 377 POSTER YM155, a novel small molecule survivin suppressant, exhibits curative antitumor activities in experimental human malignant lymphoma models in vivo. European Journal of Cancer Supplements. 4(12). 116–116. 1 indexed citations
12.
Kinoyama, Isao, Nobuaki Taniguchi, Hiroshi Koutoku, et al.. (2005). N-Arylpiperazine-1-carboxamide Derivatives: a Novel Series of Orally Active Nonsteroidal Androgen Receptor Antagonists. Chemical and Pharmaceutical Bulletin. 53(4). 402–409. 18 indexed citations
13.
14.
Kinoyama, Isao, Nobuaki Taniguchi, Hiroshi Koutoku, et al.. (2004). Synthesis and Pharmacological Evaluation of Novel Arylpiperazine Derivatives as Nonsteroidal Androgen Receptor Antagonists. Chemical and Pharmaceutical Bulletin. 52(11). 1330–1333. 13 indexed citations
15.
16.
Kanematsu, Ken & Isao Kinoyama. (1992). One-pot access to benzosulfolenes (1,3-dihydrobenzo[c]thiophene S,S-dioxides)via allenyl furfuryl (2-furylmethyl) sulfone intramolecular cycloaddition strategy. Journal of the Chemical Society Chemical Communications. 735–735. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takahito Nakahara Breakdown of academic impact, for papers by Eric C. McGary Breakdown of academic impact, for papers by Richard Karlsson Breakdown of academic impact, for papers by Vladimir Khazak Breakdown of academic impact, for papers by Alok R. Singh Breakdown of academic impact, for papers by Sara C. Murphy Breakdown of academic impact, for papers by Krista K. Bowman Breakdown of academic impact, for papers by Banibrata Sen Breakdown of academic impact, for papers by Bhairavi Tolani Breakdown of academic impact, for papers by Hidemi Hayashi
Rankless by CCL
2026